Lebenthal E, Antonowicz I, Shwachman H
Pediatrics. 1975 Oct;56(4):585-91.
Enterokinase initiates digestion of protein by conversion of trypsinogen into trypsin. The interactions between enterokinase and trysin were investigated in 6 patients with intractable diarrhea of infancy and 34 children with celiac disease. The six infants between 2 and 3 months with intractable diarrhea of infancy had reduced mucosal enterokinase activity (9.5 +/- 4.8muM per gram of protein per minute) and reduced intraluminal trypsin activity (2.9 +/- 0.7muM per gram of protein per minute) as compared with healthy controls (109 +/- 34.2muM per gram of protein per minute and 14.3 +/- 5.8muM per gram of protein per minute) respectively. The activities of all enzymes returned toward normal following treatment with intravenous alimentation. The mucosal morphology of all pretreatment biopsies in all cases showed Grade III atrophy which improved. These findings suggest that enterokinase deficiency and reduced intraluminal trypsin activity in intractable diarrhea of infancy may be one of the contributing factors to protein malabsorption and consequent malnutrition. Thirty-four children with celiac disease were between the age of 9 months and 13 years. The 11 newly diagnosed patients with celiac disease demonstrated Grade III to IV atrophy of the mucosa. The 23 patients with treated celiac disease on a gluten-free diet showed a normal to Grade II atrophy. In both treated and untreated celiac disease the enterokinase activities and the intraluminal trypsin activity were within normal limits. The enterokinase activity in celiac disease is near normal in contrast to the marked reduction noted in intractable diarrhea of infancy even though the intestinal mucosa shows marked morphological alteration and the disaccharidase activities are greatly reduced in celiac disease. After a prolonged alimentary fast of up to 26 days on intravenous alimentation, two patients with intractable diarrhea of infancy showed improvement in the activities of enterokinase and trypsin. These findings demonstrate that enterokinase and trypsin activities in the gut were present and improved in the absence of oral feeding.
肠激酶通过将胰蛋白酶原转化为胰蛋白酶来启动蛋白质消化。对6例婴儿期顽固性腹泻患者和34例乳糜泻患儿的肠激酶与胰蛋白酶之间的相互作用进行了研究。6例2至3个月大的婴儿期顽固性腹泻患儿的黏膜肠激酶活性降低(每克蛋白质每分钟9.5±4.8微摩尔),肠腔内胰蛋白酶活性降低(每克蛋白质每分钟2.9±0.7微摩尔),而健康对照者分别为(每克蛋白质每分钟109±34.2微摩尔和14.3±5.8微摩尔)。所有酶的活性在静脉营养治疗后恢复正常。所有病例治疗前活检的黏膜形态均显示为III级萎缩,且有所改善。这些发现表明,婴儿期顽固性腹泻中的肠激酶缺乏和肠腔内胰蛋白酶活性降低可能是蛋白质吸收不良及随之而来的营养不良的促成因素之一。34例乳糜泻患儿年龄在9个月至13岁之间。11例新诊断的乳糜泻患者表现出黏膜III至IV级萎缩。23例接受无麸质饮食治疗的乳糜泻患者显示为正常至II级萎缩。在治疗和未治疗的乳糜泻中,肠激酶活性和肠腔内胰蛋白酶活性均在正常范围内。与婴儿期顽固性腹泻中明显降低的情况相比,乳糜泻中的肠激酶活性接近正常,尽管乳糜泻中肠黏膜显示出明显的形态改变且双糖酶活性大幅降低。在长达26天的静脉营养长期禁食后,2例婴儿期顽固性腹泻患者的肠激酶和胰蛋白酶活性有所改善。这些发现表明,在没有经口喂养的情况下,肠道中的肠激酶和胰蛋白酶活性存在且有所改善。